News
Introducing Axatilimab (Niktimvo®) for Chronic Graft-Versus-Host Disease (cGVHD)
06/18/2025
Video
Treatment Strategies for Chronic Graft-Versus-Host Disease in Later Settings
Dr Benjamin Watkins describes treatment strategies for chronic graft-versus-host disease (cGVHD) in later lines of therapy, highlighting the use of axatilimab to address persistent disease.
Article
How Axatilimab Is Advancing Chronic Graft-Versus-Host Disease Management
A short and insightful read that reviews the pivotal trial data, clinical positioning, and practical considerations for integrating axatilimab into cGVHD management.
Podcast
Case Files: Axatilimab Use in a Patient With Chronic Graft-Versus-Host-Disease
Dr Benjamin Watkins participates in a case-based discussion on using axatilimab, including toxicity experience.
Infographic
Niktimvo™ (axatilimab-csfr) in Chronic Graft-Versus-Host Disease (cGVHD): Adverse Event (AE) Management
This easy-to-view infographic showcases adverse event management considerations to help better support patients being treated with axatilimab.
